Wealth Enhancement Advisory Services, LLC Biotechnology

Wealth Enhancement Advisory Services, LLC

$55.6 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$121B	$36.8 Million 0.07% of portfolio	82,641	Q2 2025 Added 3.06%
NVO Novo Nordisk A S	$160B	$14.1 Million 0.03% of portfolio	203,983	Q2 2025 Reduced 10.59%
INCY Incyte Corp	$15.7B	$5.64 Million 0.01% of portfolio	82,835	Q2 2025 Added 3.89%
EXEL Exelixis, Inc.	$14.4B	$5.25 Million 0.01% of portfolio	119,011	Q2 2025 Added 8.16%
REGN Regeneron Pharmaceuticals, Inc.	$60.5B	$5.07 Million 0.01% of portfolio	9,662	Q2 2025 Reduced 71.37%
BMRN Biomarin Pharmaceutical Inc	$11.1B	$4.09 Million 0.01% of portfolio	74,381	Q2 2025 Added 66.83%
CRSP Crispr Therapeutics Ag	$5.15B	$4.02 Million 0.01% of portfolio	82,607	Q2 2025 Reduced 12.21%
AXSM Axsome Therapeutics, Inc.	$4.5B	$2.16 Million 0.0% of portfolio	20,678	Q2 2025 Added 0.16%
UTHR United Therapeutics Corp	$13.9B	$1.75 Million 0.0% of portfolio	6,084	Q2 2025 Added 77.43%
APLS Apellis Pharmaceuticals, Inc.	$2.21B	$1.74 Million 0.0% of portfolio	100,666	Q2 2025 Added 43.48%
ALNY Alnylam Pharmaceuticals, Inc.	$40.4B	$1.67 Million 0.0% of portfolio	5,118	Q2 2025 Reduced 64.47%
TECH Bio Techne Corp	$2.29B	$1.06 Million 0.0% of portfolio	20,672	Q2 2025 Added 3.55%
CORT Corcept Therapeutics Inc	$7.24B	$1 Million 0.0% of portfolio	13,647	Q2 2025 Added 71.57%
HALO Halozyme Therapeutics, Inc.	$8.19B	$737,000 0.0% of portfolio	14,171	Q2 2025 Reduced 31.94%
RPRX Royalty Pharma PLC	$16B	$727,000 0.0% of portfolio	20,201	Q2 2025 Added 23.48%
CPRX Catalyst Pharmaceuticals, Inc.	$2.16B	$689,000 0.0% of portfolio	31,755	Q2 2025 Reduced 10.13%
MIRM Mirum Pharmaceuticals, Inc.	$1.92B	$602,000 0.0% of portfolio	11,845	Q2 2025 Reduced 29.01%
JAZZ Jazz Pharmaceuticals PLC	$7.4B	$576,000 0.0% of portfolio	5,429	Q2 2025 Added 25.27%
ACAD Acadia Pharmaceuticals Inc	$3.73B	$525,000 0.0% of portfolio	24,375	Q2 2025 New
PTCT Ptc Therapeutics, Inc.	$3.31B	$525,000 0.0% of portfolio	10,753	Q2 2025 Reduced 7.86%
IMNM Immunome Inc.	$132M	$494,000 0.0% of portfolio	53,187	Q2 2025 Added 3.19%
BPMC Blueprint Medicines Corp	$7.73B	$448,000 0.0% of portfolio	3,497	Q2 2025 Added 4.29%
INSM Insmed Inc	$14B	$447,000 0.0% of portfolio	4,446	Q2 2025 Added 17.87%
MRNA Moderna, Inc.	$13.3B	$424,000 0.0% of portfolio	15,386	Q2 2025 Added 24.3%
VRNA Verona Pharma PLC	$6.4B	$401,000 0.0% of portfolio	4,249	Q2 2025 New
CRMD Cor Medix Inc.	$480M	$358,000 0.0% of portfolio	29,114	Q2 2025 Added 5.35%
CELC Celcuity Inc.	$206M	$350,000 0.0% of portfolio	26,269	Q2 2025 Reduced 1.02%
VCYT Veracyte, Inc.	$1.69B	$350,000 0.0% of portfolio	12,953	Q2 2025 Reduced 28.83%
BCRX Biocryst Pharmaceuticals Inc	$1.59B	$338,000 0.0% of portfolio	37,766	Q2 2025 Added 0.25%
KURA Kura Oncology, Inc.	$433M	$328,000 0.0% of portfolio	56,912	Q2 2025 Added 169.3%
RARE Ultragenyx Pharmaceutical Inc.	$1.91B	$321,000 0.0% of portfolio	8,848	Q2 2025 New
IONS Ionis Pharmaceuticals Inc	$5.98B	$312,000 0.0% of portfolio	7,915	Q2 2025 New
SAGE Sage Therapeutics, Inc.	$521M	$310,000 0.0% of portfolio	34,046	Q2 2025 Reduced 21.98%
LGND Ligand Pharmaceuticals Inc	$2.24B	$296,000 0.0% of portfolio	2,604	Q2 2025 Added 1.2%
CYTK Cytokinetics Inc	$3.51B	$280,000 0.0% of portfolio	8,476	Q2 2025 Added 30.64%
GMAB Genmab A/S	$15.6B	$262,000 0.0% of portfolio	12,685	Q2 2025 New
ARDX Ardelyx, Inc.	$656M	$254,000 0.0% of portfolio	65,030	Q2 2025 Added 21.93%
RGNX Regenxbio Inc.	$395M	$251,000 0.0% of portfolio	30,630	Q2 2025 Added 78.37%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.72B	$246,000 0.0% of portfolio	15,580	Q2 2025 New
VKTX Viking Therapeutics, Inc.	$2.57B	$238,000 0.0% of portfolio	8,993	Q2 2025 New
SMMT Summit Therapeutics Inc.	$5.61B	$225,000 0.0% of portfolio	10,578	Q2 2025 New
ARQT Arcutis Biotherapeutics, Inc.	$904M	$219,000 0.0% of portfolio	15,666	Q2 2025 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.12B	$212,000 0.0% of portfolio	701	Q2 2025 New
ZNTL Zentalis Pharmaceuticals, Inc.	$83.8M	$201,000 0.0% of portfolio	174,006	Q2 2025 Reduced 25.66%
AVXL Anavex Life Sciences Corp.	$993M	$159,000 0.0% of portfolio	17,305	Q2 2025 Reduced 23.52%
RLAY Relay Therapeutics, Inc.	$442M	$141,000 0.0% of portfolio	40,983	Q2 2025 Added 164.88%
GERN Geron Corp	$484M	$139,000 0.0% of portfolio	99,258	Q2 2025 Added 4.85%
SANA Sana Biotechnology, Inc.	$976M	$138,000 0.0% of portfolio	50,849	Q2 2025 Added 68.02%
ADPT Adaptive Biotechnologies Corp	$1.52B	$134,000 0.0% of portfolio	11,576	Q2 2025 Reduced 1.45%
XERS Xeris Biopharma Holdings, Inc.	$703M	$124,000 0.0% of portfolio	26,758	Q2 2025 Reduced 14.39%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.